Literature DB >> 9372675

Comparison of train-of-four and best clinical assessment during continuous paralysis.

C Strange1, L Vaughan, C Franklin, J Johnson.   

Abstract

Train-of-four (TOF) monitoring is recommended in published guidelines during use of continuous-infusion neuromuscular blocking agents (NMB) in the intensive care unit (ICU). To test that recommendation, dual protocols were established in a medical ICU after intensive nursing education. Paralyzed patients received either TOF monitoring with a goal of three twitches or best clinical assessment while receiving atracurium by continuous infusion. Demographics and mean duration of paralysis of 20 patients in the TOF group were no different than that of the 16 patients in the best clinical assessment group. Although most patients demonstrated atracurium tolerance over time, there was no difference between groups in total mg (+/- SEM) infused (10,460 +/- 2,409 versus 9,201 +/- 3,237) or mean microgram/kg/min (15.2 +/- 1.5 versus 12.0 +/- 1.1). The time to clinical recovery was no different between groups (50 +/- 10 versus 45 +/- 12 min). Two complications occurred in the TOF group, with pulmonary emboli despite prophylaxis and an unrecognized cerebrovascular accident in one patient each. We conclude that careful titration of NMB using clinical bedside markers should remain the standard of care with these drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372675     DOI: 10.1164/ajrccm.156.5.9701079

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

Review 2.  Use of neuromuscular blocking agents in acute respiratory distress syndrome.

Authors:  G Tsai-Nguyen; Ariel M Modrykamien
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-02-23

3.  Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.

Authors:  David T Huang; Derek C Angus; Marc Moss; B Taylor Thompson; Niall D Ferguson; Adit Ginde; Michelle Ng Gong; Stephanie Gundel; Douglas L Hayden; R Duncan Hite; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; Kathleen D Liu; Daniel S Talmor; Donald M Yealy
Journal:  Ann Am Thorac Soc       Date:  2017-01

4.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2007-12-04       Impact factor: 17.440

6.  How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.

Authors:  Sami Hraiech; Jean-Marie Forel; Christophe Guervilly; Romain Rambaud; Samuel Lehingue; Mélanie Adda; Pierre Sylla; Sabine Valera; Julien Carvelli; Marc Gainnier; Laurent Papazian; Jérémy Bourenne
Journal:  Ann Intensive Care       Date:  2017-08-02       Impact factor: 6.925

7.  Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.

Authors:  Pierre Bouju; Jean-Marc Tadié; Nicolas Barbarot; Julien Letheulle; Fabrice Uhel; Pierre Fillatre; Guillaume Grillet; Angélique Goepp; Yves Le Tulzo; Arnaud Gacouin
Journal:  Ann Intensive Care       Date:  2017-01-19       Impact factor: 6.925

8.  The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients.

Authors:  Sarah Hadique; Varun Badami; Michael Forte; Nicole Kovacic; Amna Umer; Amanda Shigle; Jordan Gardo; Rahul Sangani
Journal:  Crit Care Explor       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.